Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients

The British Journal of Dermatology
R C BeckersB W Boom

Abstract

At present, initial high-dose prednisone is the treatment of choice for patients with pemphigus and bullous pemphigoid. To reduce the risks associated with long-term corticosteroid treatment, other immunosuppressants are often given as steroid-sparing agents. Occasionally, the dose of steroids cannot be reduced. In this study, we report six patients with pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid, in whom the daily corticosteroid dose could only be tapered to acceptable, effective, maintenance levels following treatment with high-dose intravenous gammaglobulin.

References

Feb 1, 1976·Archives of Dermatology·N S PenneysP Frost
Jan 9, 1992·The New England Journal of Medicine·J M Dwyer
Feb 1, 1990·Journal of the American Academy of Dermatology·P HumbertP Agache
Dec 1, 1985·Annals of Internal Medicine·W GodardG Rifle
Apr 1, 1989·Journal of the American Academy of Dermatology·G Tappeiner, A Steiner
Jun 1, 1988·Journal of the American Academy of Dermatology·H BarthelemyJ Thivolet
Nov 1, 1984·Journal of the American Academy of Dermatology·Y PoulinS A Muller
Mar 1, 1983·Archives of Dermatology·J C RoujeauR Touraine
Jan 1, 1993·Journal of the American Academy of Dermatology·I ThomasD M Arbesfeld

❮ Previous
Next ❯

Citations

Jun 27, 2009·Clinical Reviews in Allergy & Immunology·Norito IshiiRalf J Ludwig
Nov 14, 2001·Clinics in Dermatology·A S EkongM R Roque
Nov 14, 2001·Clinics in Dermatology·F WojnarowskaN Khumalo
Apr 12, 2000·International Journal of Dermatology·C A EganJ J Zone
Feb 12, 1998·The British Journal of Dermatology·M L UrcelayW S Douglas
May 17, 2005·Drugs·Scott R A WalshP Régine Mydlarski
Jun 10, 2004·American Journal of Clinical Dermatology·Anita Ruetter, Thomas A Luger
Oct 29, 2005·American Journal of Clinical Dermatology·Shih Wei YehRazzaque A Ahmed
Sep 19, 2009·Drugs & Aging·Oliver A Perez, Timothy Patton
Jan 5, 2002·The Journal of Dermatology·K Takamori
Jul 23, 2004·Expert Opinion on Investigational Drugs·A Razzaque Ahmed
Feb 18, 2016·International Journal of Inflammation·Lyubomir A DourmishevLjubka G Miteva
Dec 6, 2011·Clinics in Dermatology·Donna A Culton, Luis A Diaz
Mar 15, 2011·Annales de dermatologie et de vénéréologie·P Joly, C Sin
Dec 17, 2004·Annales de dermatologie et de vénéréologie·A LevyV Descamps
Dec 19, 2006·Seminars in Cutaneous Medicine and Surgery·Mary Jo J KernsMichael P Heffernan
Jul 22, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·D IoannidesD Rigopoulos
Nov 1, 2007·Dermatologic Therapy·Anthony P Fernandez, Francisco A Kerdel
Nov 6, 2012·The British Journal of Dermatology·V A VenningG Kirtschig
Dec 6, 2012·Dermatologic Therapy·Luis Dehesa, Antonella Tosti
Dec 8, 2004·Journal of the American Academy of Dermatology·Alexander KreuterPeter Altmeyer
Dec 28, 2006·Journal of the American Academy of Dermatology·David I SmithMichael P Heffernan
Jan 8, 2000·Dermatologic Clinics·J L Popovsky, C Camisa
Jan 8, 2000·Dermatologic Clinics·N J Korman
Nov 14, 2001·Dermatologic Clinics·N J Korman
Sep 20, 2011·Autoimmunity·Annette CzernikSergei A Grando
Nov 18, 2006·Expert Opinion on Pharmacotherapy·Timothy Patton, Neil J Korman
Dec 2, 2000·Journal of the American Academy of Dermatology·L EngineerA R Ahmed
Mar 1, 2006·International Immunopharmacology·A Razzaque Ahmed
May 18, 1999·Dermatologic Clinics·M Glied, M J Rico
Apr 19, 2007·The Annals of Pharmacotherapy·Hakan M Gürcan, A Razzaque Ahmed
Sep 25, 1998·The British Journal of Dermatology·L ColonnaP Puddu
May 11, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·S BaumH Trau
Nov 25, 2003·The British Journal of Dermatology·K E HarmanUNKNOWN British Association of Dermatologists

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.